Exodus Point Capital Management, LP Y M Abs Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$4.86 - $7.23 $60,137 - $89,464	-12,374 Reduced 46.69%	14,126 $77,000
Q2 2023 Aug 10, 2023	BUY	$5.68 - $10.34 $150,520 - $274,010	26,500 New	26,500 $180,000
Q4 2021 Feb 11, 2022	SELL	$15.51 - $29.31 $269,858 - $509,964	-17,399 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$27.47 - $37.31 $10,960 - $14,886	399 Added 2.35%	17,399 $497,000
Q2 2021 Aug 16, 2021	BUY	$25.45 - $37.64 $432,650 - $639,880	17,000 New	17,000 $575,000
Q3 2020 Nov 16, 2020	SELL	$35.13 - $43.62 $178,952 - $222,200	-5,094 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$23.66 - $49.53 $120,524 - $252,305	5,094 New	5,094 $220,000

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.